0918 TIB preclin QT
BioCentury & Getty Images

Translation in Brief

Gene therapies from Passage Bio, Locanabio; Lava’s antitumor bispecific, health disparities in Alzheimer’s and more

BioCentury’s roundup of translational news

BioCentury’s roundup of translational news.

Sep 19, 2020 | 1:15 AM GMT

Passage Bio’s frontotemporal dementia gene therapy
University of

Read the full 459 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE